首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2014篇
  免费   80篇
  国内免费   1篇
  2095篇
  2020年   35篇
  2019年   28篇
  2018年   42篇
  2017年   45篇
  2016年   59篇
  2015年   32篇
  2014年   35篇
  2013年   220篇
  2012年   60篇
  2011年   71篇
  2010年   41篇
  2009年   54篇
  2008年   75篇
  2007年   84篇
  2006年   55篇
  2005年   64篇
  2004年   59篇
  2003年   46篇
  2002年   44篇
  2001年   51篇
  2000年   31篇
  1999年   30篇
  1998年   27篇
  1997年   30篇
  1996年   30篇
  1995年   21篇
  1993年   16篇
  1992年   26篇
  1991年   41篇
  1990年   25篇
  1989年   25篇
  1988年   22篇
  1987年   26篇
  1986年   23篇
  1985年   29篇
  1984年   24篇
  1983年   21篇
  1982年   32篇
  1981年   20篇
  1980年   20篇
  1979年   26篇
  1978年   26篇
  1977年   24篇
  1976年   18篇
  1975年   28篇
  1974年   27篇
  1973年   28篇
  1972年   20篇
  1968年   22篇
  1966年   21篇
排序方式: 共有2095条查询结果,搜索用时 15 毫秒
991.
Psychologists in medical schools, teaching hospitals, and academic medical centers are comparatively small in number, and are often undervalued and denied full practice privileges. As a profession, psychologists must therefore adapt to the realities of a physician-driven, physician-controlled environment. Psychologists’ adaptation to academic medical settings has been considered from several vantage points. An overlooked aspect of adaptation is psychologists’ knowledge of and participation in academic medicine organizations that regulate medical education and specialization. These organizations significantly influence teaching hospital and medical school environments and the psychologists and academic physicians who work in those environments. This paper focuses primarily on three academic medicine organizations, the Liaison Committee on Medical Education (LCME), the Accreditation Council for Graduate Medical Education (ACGME), and the American Board of Medical Specialties (ABMS), which together shape and regulate medical education across all levels and specialties. Knowledge of the evolution and workings of these organizations is useful information for psychologists, but beyond that, such information is a framework that provides benchmarks for understanding psychology’s evolving system of education and specialization.  相似文献   
992.
993.
994.
995.
996.
997.
998.
999.
Lisa Director proposes a relational model with an emphasis on enactment for the treatment of chronic drug and alcohol use. She illustrates her thesis with an extensive case report. The story of her patient's addiction, and of the embroiled analytic developments, is engaging, disturbing, and rewarding. I suggest that the telling of this inspiring story, and the narration of her theoretical framework, is a response to the devastation involved in the encountering of addictions and that this story unintentionally obscures some basic issues about addiction and the psychoanalytic treatment of it. I believe that the survival of patient and analyst was achieved with the help of three underemphasized factors: Director is an expert in the assessment and treatment of chemical dependency problems, and her patient, Helena, knew this; despite her chronic addiction, Helena brought exceptional resources for survival to the analysis; and the authority of the analyst was used for leverage to help replace Helena's reliance on drinking and drugs.  相似文献   
1000.
Identification and comprehensive care of individuals who have Fabry disease (FD) requires a multidisciplinary approach inclusive of genetic testing, test interpretation, genetic counseling, long term disease symptom monitoring, treatment recommendations, and coordination of therapy. The purpose of this document is to provide health care professionals with guidelines for testing, care coordination, identification of psychosocial issues, and to facilitate a better understanding of disease treatment expert recommendations for patients with Fabry disease. These recommendations are the opinions of a multicenter working group of genetic counselors, medical geneticists, and other health professionals with expertise in Fabry disease counseling, as well as representatives/founders of the two United States based Fabry disease patient advocacy groups who are themselves affected by Fabry disease. The recommendations are U.S. Preventive Task Force Class III, and they are based on clinical experience, a review of pertinent English-language articles, and reports of expert committees. This document reviews the genetics of Fabry disease, the indications for genetic testing, interpretation of results, psychosocial considerations, and references to professional and patient resources.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号